TIRZEPATIDE·ALABAMA·VERIFIED MAY 13, 2026

Is Tirzepatide legal in Alabama?

CAVEATS APPLY

FDA-approved GIP/GLP-1 dual agonist (Mounjaro/Zepbound); compounded copies broadly restricted post-shortage; FDA has issued 30+ Warning Letters to GLP-1 telehealth vendors. Alabama AG TRO + Jan 2026 settlement against Aurora IV & Wellness (Cullman) for advertising 'pharmaceutical-grade' tirzepatide while injecting research-grade product; permanent closure + bar on operators.

CATEGORY · FDA APPROVED

Full status breakdown

FEDERAL · STATE · SPORT-BODY

Federal status

FDA approval

approved as drug · brand: Mounjaro, Zepbound · NDA 215866 (Mounjaro); NDA 217806 (Zepbound) · approved May 13, 2022

Indications: T2DM; chronic weight management; OSA

FDA SOURCE ↗

DEA scheduling

not scheduled

DEA ORANGE BOOK ↗

503A compounding

Bulks list: not on list

Do-not-compound list: not on list

Approved drug; 503A 'essentially a copy' rule applies post-shortage. 503A enforcement discretion ended Feb 18, 2025; 503B Mar 19, 2025. FDA proposed April 2026 to exclude tirzepatide from 503B bulks list.

SOURCE ↗

FDA Warning Letters

Dec 10, 2024 — Summit Research Peptides (cited: tirzepatide, retatrutide) · LETTER ↗
Sep 9, 2025 — Hims & Hers Health Inc dba Hers (cited: tirzepatide, semaglutide) · LETTER ↗
Feb 20, 2026 — Better Health Labs Inc dba Measured (cited: tirzepatide) · LETTER ↗
Mar 31, 2026 — Gram Peptides (cited: tirzepatide, retatrutide) · LETTER ↗

Shortage status

not currently on shortage list

Historical shortage window: Apr 1, 2024 → Dec 19, 2024

SOURCE ↗

Sale framing

Research-use-only posture: RUO label does not legalize sale to consumers when site evidence shows human-use intent. FDA has issued 30+ warning letters across 2024-2026.

Personal possession: Federally unscheduled; possession by an end-user is not a federal criminal offense, but unapproved compounded/illicit tirzepatide carries FDA enforcement risk on the seller side plus state pharmacy law risk.

SOURCE 1 ↗SOURCE 2 ↗

Alabama — state-specific

consumer protection action · Alabama

Alabama AG TRO + Jan 2026 settlement against Aurora IV & Wellness (Cullman) for advertising 'pharmaceutical-grade' tirzepatide while injecting research-grade product; permanent closure + bar on operators.

Alabama AG — Aurora IV suit ↗ · verified May 13, 2026

Sport-body status

WADA 2026

on prohibited list · class S2 · both

S2 (Peptide hormones / GLP-1 agonist class). WADA does not name tirzepatide explicitly; class-language capture.

WADA LIST ↗

USADA

banned

SOURCE ↗

NCAA

banned

SOURCE ↗

What we couldn’t verify

Also known as

6 ALIASES

Tirzepatide is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

LY3298176
Mounjaro
Zepbound
GIP/GLP-1 dual agonist
Tirz
Tirze

FOLLOW-ONS

Back to peptide legality lookup — pick a different compound or state
Tirzepatide research guide — mechanism, dosing math, vendor audits, COA data
Peptide pricing index — what each compound costs per mg across audited vendors
Janoshik COA verifier — a separate question from legality: does the COA the vendor cites actually exist?

Tirzepatide legality in other US states

State-by-state legal status for the same compound. Federal classification holds, state law varies.

Is Tirzepatide legal in Alabama?

Full status breakdown

Federal status

Alabama — state-specific

Sport-body status

What we couldn’t verify

Also known as

Related

Tirzepatide legality in other US states

Receipts in your inbox. Once a month.